Kheiron Medical

Kheiron Medical was founded in London in 2016 with the sole focus of helping radiologists detect breast cancer earlier with machine learning software. Kheiron offers a breast-screening product called Mia, which serves as a “second reader” to help radiologists decide whether to recall a patient for further evaluation. It’s designed as a supportive tool rather than to replace medical professionals — an automated second opinion. In 2019 they raised $22m in Series A round of funding led by Atomico, with participation from Greycroft, Connect Ventures, Hoxton Ventures, and Exor Seeds.

Scroll Up
Share This